Objective. Repetitive transcranial magnetic stimulation (rTMS) has been shown to effectively treat depression, and its potential value in pain management is emphasized by recent studies. Transcranial magnetic stimulation (TMS)-evoked activity in the prefrontal cortex may be associated with corticolimbic inhibitory circuits capable of decreasing pain perception. The present exploratory pilot study used functional magnetic resonance imaging (fMRI) to examine the effects of left prefrontal rTMS on brain activity and pain perception. Results. TMS was associated with a 13.30% decrease in pain ratings, while sham was associated with an 8.61% decrease (P = 0.04). TMS was uniquely associated with increased activity in the posterior cingulate gyrus, precuneous, right superior frontal gyrus, right insula, and bilateral postcentral gyrus. Activity in the right superior prefrontal gyrus was negatively correlated with pain ratings (r = -0.65, P = 0.02) in the real TMS group.
Introduction
The brain's response to pain is complex and involves anticipation, pain encoding and perception, affective responses, cognitive evaluation, and behavioral responses [1] . Imaging studies with functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) show that thermal stimulation increases blood flow in multiple brain regions including the orbital frontal and dorsolateral prefrontal cortex (DLPFC), anterior and posterior cingulate gyrus, thalamus, motor cortex, and supplemental motor area, primary and secondary somatosensory cortex, insula, cerebellum, and lenticular nucleus [2] [3] [4] [5] . Emerging research reveals that increased activity in the DLPFC and orbitofrontal cortices is negatively correlated with reported pain [4, [6] [7] [8] [9] . Increased activity in these regions has also been correlated with increased activity in the periaqueductal gray matter (PAG) and lower pons [4, 6] . Several of these regions may provide potential modulatory targets for pain relief.
Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technology that can be used in awake individuals. A localized pulsed magnetic field transmitted through a figure 8 coil induces electrical currents in the brain [6] [7] [8] [9] . The effects of TMS depend on the frequency, intensity, location, and angle of application. Different paradigms can activate different neuronal populations and cellular elements [6] [7] [8] [9] . Repetitive TMS (rTMS) over the left prefrontal cortex has been shown to be effective in the treatment of depression [10] [11] [12] [13] [14] , and its use was approved by the Food and Drug Administration in 2008 as a therapy for treatment-resistant depression. Although the mechanisms of action are largely unknown, some imaging studies exploring the effects of TMS on the brain are emerging. An interleaved TMS-fMRI study by Li et al. revealed that rTMS over the left DLPFC is associated with increased blood flow at the site of application, as well as in limbic structures. Increased blood flow was observed in the bilateral medial prefrontal cortex, contralateral orbital frontal cortex, ipsilateral hippocampus, dorsomedial nucleus of the thalamus, and bilateral putamen, pulvinar, and insula [15] .
There is now convincing evidence that rTMS has the potential to help management chronic pain conditions as well, but most of the work in this area has focused on stimulation of the motor cortex [16] [17] [18] [19] [20] [21] . As many of the same prefrontal and limbic circuits are thought to be involved in mood regulation and in the evaluation and affective response to pain, several recent studies have investigated the benefits of prefrontal rTMS in pain management. Prefrontal rTMS has been shown to significantly increase thermal and mechanical pain thresholds, as well as reduce patient-rated pain intensity in chronic pain, acute pain, and postoperative pain [7, 9, [22] [23] [24] .
Although the beneficial role of TMS in pain control is becoming clearer, relatively little is known about the mechanisms of action and the role of the prefrontal cortex in pain and mood management. While some neuroimaging studies of the effects of prefrontal rTMS in depression are beginning to emerge, to date, there are no neuroimaging studies published on the effects of prefrontal rTMS on pain perception. The present exploratory pilot study is the first of its kind to examine the effects of high-frequency left prefrontal rTMS on pain perception using fMRI technology. Ultimately, this line of research might help better articulate neural substrates and mechanisms of rTMS action in chronic pain and depression.
Methods
Twenty-three healthy adults without history of depression, chronic pain disorders, seizures, or other medical disorders volunteered to participate in this study (mean age = 26.17, standard deviation = 6.50; 14 males). The International electroencephalogram 10-20 system [25] was used to determine the location of the left DLPFC. Each participant underwent pain thresholding using the Medoc Pathway System with magnetic resonance imaging (MRI)-compatible ATS Thermode (30 ¥ 30 mm) (Medoc, Inc., Durham, NC, USA) secured on the left volar forearm via Velcro strap.
The left volar forearm was selected as the site of thermode placement due to ease of access and ability to ensure proper thermode-skin contact due to flat contour and minimal body hair. Additionally, the left arm (opposed to the right) was slightly closer to the MRI access panel making the left arm easier to access for this study. Based on prior studies, the analgesic effects of rTMS have appeared to correlate with increased activity in the right DLPFC, independent of laterality of painful sensations. The thermode began heating at 32°C and rose at a rate of 8°per second to a predetermined pseudorandom temperature between 40 and 47.5 C. After 22 seconds, the temperature fell to 32°C, and participants were asked to rate the pain on a scale from 0 (no pain) to 10 (worst pain imaginable). Ten trials were completed, and a temperature was selected, which reliably produced a pain rating of 7 out of 10. We elected to use a 0-10 scale as it is more directly comparable with the painful sensation ratings used in clinical practice. Our prior experience with rTMSinduced analgesia has been in clinical settings, in fibromyalgia patients and post-surgical patients, whose pain is evaluated by their clinicians on a 0-10 scale.
Following pain thresholding, each participant underwent a TMS motor threshold assessment. The TMS device was set to 40% of machine output, and pulses were delivered at 0.5 Hz. The coil was systematically moved about the scalp while adjusting stimulus intensity until the area of motor cortex that produced visible movement of the right abductor pollicis brevis was located. The frequency was then reduced to 0.25 Hz, and parameter estimation by sequential testing was used to estimate the resting motor threshold (the machine output necessary to produce visible thumb movement 50% of the time).
After the motor threshold assessment, subjects underwent baseline magnetic resonance imaging using a Siemens 3T Trio MRI scanner (Siemens Medical, Erlangen, Germany). The thermode was placed on the left volar forearm immediately adjacent to the previous stimulation site to avoid tissue damage. Placement was randomly ordered between adjacent locations in a 2 ¥ 2 grid within a 60 mm 2 surface of the forearm. Participants underwent an fMRI sequence while receiving heat stimuli in 22-second blocks alternating with 22-second rest periods. The temperature used was individualized for each participant (i.e., the temperature that reliably resulted in subjective ratings of 7 out of 10). The fMRI scan involved 12 pain/rest blocks over 8 minutes and 48 seconds. Each fMRI scan was acquired using a standard multislice single-shot gradient echo EPI sequence with the following parameters: TR = 2.2 seconds, TE = 35 milliseconds, 64 ¥ 64 matrix, parallel imaging factor of 2, 3 ¥ 3 ¥ 3 mm voxels, 240 volumes, and 36 ascending transverse slices with approximate AC-PC alignment. Immediately after the scan, participants were asked to rate their pain intensity on average for the entire scanning period using the 0-10 numeric rating scale.
We elected to obtain a single, post-scan pain rating as opposed to multiple real-time pain ratings for two reasons. First, we did not want to introduce noise into the functional images with possible increased neural activity in frontal processing regions associated with evaluation and quantification of the painful experience. These higher level pain processing centers may be sites of action of TMS in pain modulation, and we wished to observe the effects of TMS on these regions as cleanly as possible. We were concerned that real-time pain ratings could complicate results with activation produced by actively attending to and evaluating the pain. We felt that the scanning time was short enough that a single subjective pain rating was sufficient to quantify the perceived painfulness of the experience. We therefore evaluated the efficacy of TMS treatment based on a reduction in the ratings of painfulness of the entire procedure.
Following scanning, participants were randomly assigned to receive real rTMS (N = 12) or sham rTMS (N = 11) treatment. rTMS was performed with a Neuronetics Neopulse TMS machine with figure 8 coil (Neuronetics, Inc., Malvern, PA, USA). Sham TMS treatment was performed using the Neuronetics Neopulse sham coil (manufactured to look and sound like real TMS). The eSham System [26] was used with Thymapad Stimulus Electrodes (Somatics, LLC; Lake Bluff, IL, USA) to deliver mild, pulsed electric stimulation in-sync with the TMS pulses to further aid with masking, as rTMS has been reported to some individuals to be subjectively painful. Prior to stimulation, and in both groups, electrical stimulation intensity was systematically titrated until it produced the same subjective scalp sensation ratings as real TMS at 10 Hz at 110% of motor threshold. Patients randomly received alternating, intermittent pulses from the sham system and the rTMS system, and were asked to describe which sensation was more painful. Settings were individually titrated so that the sham pulse stimulation produced the identical subjective pain rating as the rTMS pulses. Subjects received treatment over the left DLPFC at 10 Hz and 110% of motor threshold. Treatment was applied for 15 minutes at 5 seconds on and 10 seconds off for a total of 3,000 pulses immediately following the baseline MRI scanning session. Thermal stimulation was applied in conjunction with the TMS pulses at the same temperature used during the fMRI heat trials. The thermode program was calibrated with TMS treatment such the temperature rated as 7 out of 10 was reached at the onset of the TMS pulses and persisted for the full 5 seconds. The thermode was cooled to room temperature during the 10-second rest periods. This design allowed TMS administration simultaneous with application of painful stimuli, with the goal of modulating pain perception and antinociception pathways while they were in an active state, as opposed to stimulating a potential node in the pain perception circuit while the circuit was inactive. The investigators believed that this might result in a more potent analgesic effect of the rTMS.
Following treatment, the thermode was again placed and subjects underwent a second fMRI scan using the same thermal pain paradigm. After the scanning sessions, participants were again asked to rate their perceived pain on a scale from 0 to 10. fMRI data processing was carried out using FEAT (FMRI Expert Analysis Tool) Version 5.98, part of FSL (FMRIB's Software Library, http://www.fmrib.ox.ac.uk/fsl). Functional images for each participant were first coregistered to their high-resolution structural volume. The coregistered functional images were then normalized to a common MNI template and spatially smoothed with a Gaussian FWHM kernel of 8 mm. Lower level contrasts represented pain minus rest for all scans. Higher level analysis was carried out using a fixed effects model by forcing the random effects variance to zero in FLAME (FMRIB's Local Analysis of Mixed Effects) [5, 27, 28] . Z (Gaussianised T/F) statistic images were thresholded using clusters determined by z > 2.3 and a corrected cluster significance threshold of P = 0.05 [29] .
Results
There were no differences between the real and sham rTMS groups with respect to age, sex, temperature used, motor threshold, pre-TMS pain/unpleasantness ratings, proportion of subjects correctly guessing which TMS condition they received, or confidence ratings in condition guesses (see Table 1 ). The average temperature required to produce a pain rating of 7 out of 10 was 46.32°C and 46.57°C in the sham and real groups, respectively. Real TMS was associated with a 13.30% decrease in subjective pain ratings, and sham was associated with an 8.61% decrease. The mixed model examining the change in pain ratings (slope) between groups (real vs sham) indicated that the pain rating changes were significantly different from zero (pre-to post-TMS treatment) in both the real TMS group (t [21] = 3.53, P = 0.002) and the sham group (t [21] = 2.09, P = 0.049). However, the interaction of time (pre-vs post-TMS) and condition (real vs sham) was significant (t [22] = 3.29, P = 0.0034) and post-hoc analysis suggested that real TMS had a larger effect on pain ratings than sham (see Figure 1) . While the change in pain ratings seen in the real rTMS was statistically significant, a 13% reduction would likely not be considered clinically meaningful.
Analysis of the pretreatment fMRI scans for all subjects (pain minus rest contrast) revealed activation of cortical and subcortical areas commonly seen in response to thermal pain stimuli [3, 30, 31] . Blood flow was increased bilaterally in the thalamus, orbital frontal, superior frontal gyrus, insular, and anterior cingulate cortices, as well as in the lenticular nucleus and tegmentum (see Figure 2) . Table 2 shows the Tailarach x, y, z coordinates, region name, and the z-values.
Real TMS (post-minus pre-stimulation) was associated with significantly increased activation of superior frontal gyrus, anterior cingulate, bilateral thalamus, bilateral insula, supramarginal gyrus, precentral gyrus, and posterior cingulate in response to painful stimuli (see Figure 3 and Table 3 ). Sham TMS was associated with increased activity in bilateral thalamus and insula (see Figure 4 and Table 4 ). The mixed model (post-minus pre-TMS, and real minus sham TMS) suggests that real TMS was uniquely associated with activity in the posterior cingulate gyrus, precuneous, right superior frontal gyrus, right insula, and bilateral postcentral gyrus (see Figure 5 and Table 5 ) over and above sham.
Exploratory region of interest analysis (uncorrected for multiple comparisons) revealed that the activity in the right superior prefrontal gyrus was significantly and negatively correlated with subject-reported pain ratings (r = -0.65, P = 0.02) in the real TMS group. This suggests that increased activity in this region may be associated with the lower post-TMS subjective pain ratings (see Figures 6  and 7) .
Discussion
The present study found that high-frequency rTMS over the left DLPFC produced slightly greater reductions in subject pain rating of thermal stimuli than found with sham treatment. Real treatment was uniquely associated with increased activity in several areas, including the right superior frontal gyrus and insula, and anterior and posterior cingulate gyri. Increased superior frontal activity was significantly associated with decreased pain intensity ratings. Following sham treatment, high levels of activity were found in areas of pain processing such as the bilateral thalamus and caudate, as well as in the precentral gyrus. Lower level group analyses also showed brainstem activity in the sham group in response to painful stimuli, while real treatment showed no brainstem activity suggesting that real TMS over the prefrontal cortex may Activity in the left DLPFC has been shown by PET imaging to have a negative association with subjective pain experience. Lorenz et al. proposed that this may be due to the association of high activity in the left DLPFC with weakened activation of the thalamus and midbrain [4] . Although we did not see decreased blood flow to the thalamus following TMS, we did find an absence of midbrain activity that was present in post-sham treatment scans. However, the significance of the differential brain stem activation was lost during the higher level mixed-model analyses possibly due to small sample size.
Many recent imaging studies emphasize the importance of the prefrontal cortex in pain modulation and antinociception [4, [6] [7] [8] [9] [31] [32] [33] [34] [35] [36] . Interestingly, many of the same areas of activation are found to be involved in analgesia produced by so-called placebo effects [32] , active cognitive pain suppression [31] , and motor cortex stimulation [33] [34] [35] [36] . At least two pathways have been proposed in cortical modulation of painful stimuli. First, the cingulate cortex and DLPFC seem to be involved in the emotional appraisal of pain [4, 31, 32, 34, 36] . Additionally, the prefrontal cortex appears to be involved in initiation of descending antinociceptive circuits involving the basal ganglia [31, 32, 34, 36] and brainstem PAG [33] [34] [35] [36] ; Maarrawi et al. [35] reported decreased binding of [ cortex (ACC), PAG, prefrontal cortex, and cerebellum following motor cortex stimulation via implanted epidural electrodes, suggesting increased receptor occupancy due to enhanced secretion of endogenous opioids. These findings were correlated with reported reduction in pain in at least two of the structures further supporting a descending cortical inhibitory pathway involving increased secretion of endogenous opioids.
High-frequency rTMS over the left DLPFC has been shown to increase blood flow at the site of the stimulation [37] , although activation in this area was not seen in our small sample size, but the present study found a significant negative association between increased activity in the right superior frontal gyrus and pain ratings following left prefrontal rTMS. Lorenz et al. [4] reported similar findings of decreased pain intensity and unpleasantness associated with high DLPFC activity. Interestingly, their study also found that high bilateral activation of the ACC was still present during heightened activity in the right DLPFC. However, this activation was dissociated from pain intensity and unpleasantness ratings. They reported that the relationship between anterior insular activity, and pain intensity and unpleasantness was dependent on the magnitude of activity in the right DLPFC. A high positive correlation between anterior insular activity, and pain intensity and unpleasantness was noted during low right DLPFC activation; this association was not observed One would expect that increased activity in the insula and somatosensory cortex during painful stimuli, as seen in the post-TMS condition, might actually be associated with increased pain. We are unsure of the significance of this finding. However, fMRI is only capable of indirectly measuring brain activity based on increased hemodynamic response. An increased BOLD response simply indicates an increase in oxygen delivery to the tissue. It is impossible to say which types of neurons have increased activity and whether they are part of excitatory or inhibitory pathways. Therefore, it is possible that increased blood flow could be due to activation of regulatory or inhibitory interneuron-releasing neurotransmitters to decrease the normal nociceptive pathways in those areas. An alternate explanation is that while TMS decreases subjective pain experience from the thermal site, it does provide mildly painful stimulation to the skull, which could explain increased activity in sensoryprocessing regions such as the insula. A limitation of the current study is the small sample size, which limits generalizability. Additionally, although real rTMS produced significantly greater pain reduction than sham treatment, some reduction in pain ratings was observed following sham treatment. One possible explanation for this is placebo analgesia. So-called placebo analgesia is thought to produce real antinociceptive effects possibly through the release of endogenous opioids, as evidenced by the reversal of placebo analgesic effects with opioid antagonists [32, 38, 39] . This would be supported by increased midbrain activity following sham treatment, although this finding would need to be reproduced in larger sample sizes. Alternatively, pain ratings may have been higher in both groups during the pretreatment fMRI heat trials due to anxiety or anticipation. Many subjects had never been in an MRI scanner before, and none had experienced the pain trials except for during thresholding. Also, increased attention to the painful stimuli or increased anxiety could both reduce pain thresholds. Finally, the present study was conducted on healthy controls, and it is unclear whether findings from the present study might generalize to patients with chronic pain.
In spite of these limitations, this study presents preliminary evidence that distinct regional brain activity in response to Figure 6 Exploratory region of interest analysis of pain processing activity (pain minus rest) in the right superior frontal gyrus post-transcranial magnetic stimulation (TMS) minus pre-TMS.
Figure 7
Scatter-plot of changes in subjective pain ratings postminus pre-real transcranial magnetic stimulation against mean signal change in the right superior frontal gyrus. ROI = region of interest.
painful stimuli can be modulated by high-frequency rTMS over the left DLPFC and produce significant pain reduction compared with sham treatment. In particular, increased activity in the right superior prefrontal gyrus had a significant negative association with pain intensity ratings following rTMS. However, the precise nature by which the altered activation reduces pain intensity has yet to be elucidated. Larger follow-up studies are needed in this area to elucidate how TMS may modulate cortical and subcortical networks involved in pain perception.
